Protai

Protai is celebrating its 3rd anniversary, marking three successful years of pioneering Proteomics & AI driven drug discovery. 2 cutting-edge drug programs are making rapid progress towards the clinic, with several others on the way. Our brand new lab signifies a pivotal moment as we unite our computational and biological teams under one roof, fostering seamless collaboration and innovation. Great collaborations with top biotech and scientific institutions worldwide are driving impactful outcomes. I'm inspired by the incredible team that has joined our journey - together, we're ready to achieve remarkable things. Kirill Pevzner, Tami Geiger, Sharon Shacham, Giulio Draetta, Gali Arad, Nitzan Simchi, Anjana Shenoy, Lior Handelsman, Ittai Harel #Protai #anniversary #proteomics #ai #drugdiscovery #Teamwork

Protai will be attending BIO International in San Diego. Meet our team to hear more about our AI Proteomics drug discovery platform. #bio24 #protai #proteomics #ai Eran Seger | Kirill Pevzner

Meet us at #ASCO Meet Protai at ASCO to learn about our precision oncology pipeline and unique proteomics & AI platform for biomarkers and drug discovery. #ASCO24 #protai #proteomics #AI Kirill Pevzner | Eran Seger

Come to hear about Precision medicine at Protai from Eran Seger, our CEO and co-founder, and learn about how the OrganoSphere initiative is going tp impact the Israeli industry. Irit Carmi-Levy | Eran Seger #PrecisionMedicine #Protai #OrganoSphere #HealthcareInnovation

Happy to update that Protai was nominated among the 50 most promising Israeli startups by Calcalist כלכליסט. #Precision #Medicine #AI #Proteomics #drug_discovery Eran Seger | Kirill Pevzner | Tami Geiger | Grove Ventures | Pitango | Maj Invest 🎗 #bring_them_home 🎗 https://lnkd.in/dAhrbs6a

We wish you all a happy holiday. We hope it brings happiness and joy to all. #bringthemhomenow 🎗️ #Protai #ai #proteomics #drugdiscovery

Summarizing a successful #AACR Annual Meeting: Protai's AIMS platform and drug pipeline were showcased in 4 posters, and our first biomarker-led drug program was launched. Additionally, we've gathered our insightful scientific advisory board, bringing together some of the world's best drug hunters. Looking forward to seeing everyone soon in #Chicago for the #ASCO Annual Meeting. #Proteomics #AI #Precision #Oncology 

At Protai, we firmly believe that investing in the next generation lays the foundation for a brighter future. building entrepreneurship and passion for science from the get-go. 💡 🔬 That’s why we’re thrilled to announce our participation in the #AtlasJuniors program! #AtlasJuniors is an innovative educational initiative that connects talented young minds from the periphery with leading startup companies in Israel. Last week marked the second session of our five-part journey with a remarkable group of seventh to eleventh-grade students. During these sessions, we not only impart knowledge on Protai’s core areas of expertise, such as AI, proteomics, and oncology, but we also provide hands-on experiences in our lab and with clinical and proteomic datasets. Additionally, we foster the development of entrepreneurial skills among participants, including public speaking, market research, and more. By empowering the next generation with both knowledge and practical skills, we’re not only investing in their future but also nurturing the innovators and leaders of tomorrow. We’re excited to continue supporting initiatives like #AtlasJuniors that drive meaningful change and inspire young minds to reach their full potential. #AtlasJuniors #Education #Innovation #FutureLeaders Boaz Arad Dr. Elina Lustov Amit Manor | Eran Seger | Kirill Pevzner

Looking forward to #AACR24! At the conference, Protai will be launching a novel, biomarker led, USP1i drug program, and presenting multiple results highlighting the advantages of the AIMS discovery platform: 1 - A novel USP1 inhibitor coupled with a novel proteomic response biomarker for precision oncology therapy. 2 - Phospho-proteomic dynamics reveal DNA damage and repair signatures of drug sensitivity. 3 -  Proteomics driven biomarker discovery for high-grade serous ovarian carcinoma from archived tissue specimens. 4 - A large scale proteogenomics atlas for precision oncology research See full details and schedule in the first comment. To schedule a meeting please contact us at: [email protected]. Eran Seger | Kirill Pevzner | Gali Arad | Nitzan Simchi #AI #Proteomics #platform #precision_oncology

Excited that our team keeps growing! Welcome to Anjana Shenoy, our new Proteomics Scientist! Anjana did her PhD in clinical cancer proteomics in Tami Geiger's lab at Tel Aviv University and continued with Mass spectrometry based Degradomics in her Post Doctorate research in Irit Sagi's lab at the Weizmann Institute of Science. Her favorite protein is PYCR1 and she is a professional Indian classical dancer. Welcome to the Protai family! 🎉 Protai #team #proteomics #massspectrometry